One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis.

Watanabe, Daichi; Iihara, Hirotoshi; Fujii, Hironori; Makiyama, Akitaka; Nishida, Shohei; Suzuki, Akio

Watanabe, Daichi; Iihara, Hirotoshi; Fujii, Hironori; Makiyama, Akitaka; Nishida, Shohei; Suzuki, Akio.

Afiliación

Watanabe D; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Fujii H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Makiyama A; Cancer Center, Gifu University Hospital, Gifu, Japan.
Nishida S; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Suzuki A; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.

Oncologist ; 27(6): e524-e532, 2022 06 08.

Article en En | MEDLINE | ID: mdl-35427418

Asunto(s)

Antieméticos; Antineoplásicos; Antineoplásicos/uso terapéutico; Carboplatino/efectos adversos; Dexametasona; Humanos; Náusea/inducido químicamente; Náusea/tratamiento farmacológico; Náusea/prevención & control; Metaanálisis en Red; Antagonistas del Receptor de Neuroquinina-1/uso terapéutico; Vómitos/inducido químicamente; Vómitos/tratamiento farmacológico; Vómitos/prevención & control

Palabras clave

1 receptor antagonists; analysis; antiemetics; antineoplastic agents; carboplatin; dexamethasone; nausea; network meta; neurokinin; vomiting

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antieméticos / Antineoplásicos Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google